欧洲疫苗市场至 2027 年 - 按技术划分的区域分析和预测（重组疫苗、结合疫苗、减毒活疫苗、灭活疫苗和亚单位疫苗以及类毒素疫苗）；疾病适应症（DTP（白喉破伤风类毒素和百日咳）、流感、肝炎、呼吸道合胞病毒（RSV）和其他疾病）；给药途径（口服、注射和其他给药途径）；患者类型（儿童患者和成人患者）和国家/地区
No. of Pages: 154 | Report Code: TIPRE00005750 | Category: Life Sciences
No. of Pages: 154 | Report Code: TIPRE00005750 | Category: Life Sciences
欧洲疫苗市场预计将从 2018 年的 95.762 亿美元增至 2027 年的 162.91 亿美元。预计 2019-2027 年市场复合年增长率为 5.5% 。
市场的增长是由欧洲疫苗接种意识提高等因素推动的欧洲疫苗研究和开发活动的增加可能会在预测期内扩大疫苗市场。然而，欧洲地区对疫苗的犹豫可能会影响预测期内疫苗市场的增长。
疫苗可以拯救生命并提高生活质量。例如，脊髓灰质炎是一种由脊髓灰质炎病毒引起的传染病，会导致肌肉无力，导致无法移动，从而进一步影响生活质量。脊髓灰质炎疫苗可以保护个人免受脊髓灰质炎的侵害。该疫苗会在血液中产生针对脊髓灰质炎病毒的抗体。由于脊髓灰质炎疫苗在欧洲的大力推广，世界卫生组织于2002年宣布欧洲地区已无脊髓灰质炎。
国家欧洲地区正在联手通过疫苗接种消除麻疹、白喉、风疹、百日咳等传染病。欧洲地区正在举办多项疫苗接种计划、运动和会议，以提高人们的认识。例如，欧洲免疫周 (EIW) 在整个欧洲地区享有盛誉，每年四月都会庆祝这一活动，以提高人们对疫苗接种对人们健康和福祉重要性的认识。欧洲疾病预防和控制中心 (ECDC) 支持世卫组织/欧洲开展的欧洲免疫周活动，并提供疫苗接种的科学证据。
此外，第38届欧洲全球疫苗峰会暨博览会疫苗接种将于 2020 年 6 月在德国法兰克福举行。会议重点讨论疫苗和免疫学研究的新策略。会议的目的是鼓励高质量的研究，并将世界一流的研究人员、国际社会和工业领袖聚集在一起，讨论疫苗和免疫学领域的新发展和创新。
由于意识计划不断增强和疫苗开发的大量资金等驱动因素，德国疫苗市场预计在预测期内将以最高速度增长。该国强劲的研发活动可能会推动该国的疫苗接种市场。预测期内该地区市场增长率预计为 6.4%。因此，考虑到上述因素，该国市场的增长很可能在预测期内为欧洲地区贡献最大份额。
< span>
按技术
欧洲疫苗 -市场细分
按疾病适应症
欧洲疫苗 –市场细分
按
管理方式
欧洲疫苗 –市场细分
按患者类型
按国家/地区
提及的公司
Strategic insights for Europe Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 9,576.2 Million |
| Market Size by 2027 | US$ 16,291.0 Million |
| Global CAGR (2019 - 2027) | 5.5% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Europe Vaccines Market
The Europe Vaccines Market is valued at US$ 9,576.2 Million in 2018, it is projected to reach US$ 16,291.0 Million by 2027.
As per our report Europe Vaccines Market, the market size is valued at US$ 9,576.2 Million in 2018, projecting it to reach US$ 16,291.0 Million by 2027. This translates to a CAGR of approximately 5.5% during the forecast period.
The Europe Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Vaccines Market report:
The Europe Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Vaccines Market
